The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits

Clin Transl Med. 2022 Sep;12(9):e1040. doi: 10.1002/ctm2.1040.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arteries
  • Atherosclerosis* / drug therapy
  • Brain
  • Central Nervous System
  • Humans
  • Neuroimmunomodulation*